ENXTPA:ELMedical Equipment
A Look At EssilorLuxottica (ENXTPA:EL) Valuation After Long-Term Dolce&Gabbana License Renewal
EssilorLuxottica Société anonyme (ENXTPA:EL) drew attention after extending its license agreement with Dolce&Gabbana through 2050, keeping exclusive rights to develop, produce, and distribute the brand’s prescription frames and sunglasses worldwide.
See our latest analysis for EssilorLuxottica Société anonyme.
The Dolce&Gabbana renewal comes at a time when EssilorLuxottica’s share price has been under pressure, with a 30-day share price return showing a decline of 17.52% and a year-to-date...